The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Metabolic determinants of cancer cell sensitivity to glucose limitation and biguanides
Open accessAbstract
As the concentrations of highly consumed nutrients, particularly glucose, are generally lower in tumours than in normal tissues, cancer cells must adapt their metabolism to the tumour microenvironment. A better understanding of these adaptations might reveal cancer cell liabilities that can be exploited for therapeutic benefit. Here we developed a continuous-flow culture apparatus (Nutrostat) for maintaining proliferating cells in low-nutrient media for long periods of time, and used it to undertake competitive proliferation assays on a pooled collection of barcoded cancer cell lines cultured in low-glucose conditions. Sensitivity to low glucose varies amongst cell lines, and an RNA interference (RNAi) screen pinpointed mitochondrial oxidative phosphorylation (OXPHOS) as the major pathway required for optimal proliferation in low glucose. We found that cell lines most sensitive to low glucose are defective in the OXPHOS upregulation that is normally caused by glucose limitation as a result of either mitochondrial DNA (mtDNA) mutations in complex I genes or impaired glucose utilization. These defects predict sensitivity to biguanides, antidiabetic drugs that inhibit OXPHOS, when cancer cells are grown in low glucose or as tumour xenografts. Notably, the biguanide sensitivity of cancer cells with mtDNA mutations was reversed by ectopic expression of yeast NDI1, a ubiquinone oxidoreductase that allows bypass of complex I function. Thus, we conclude that mtDNA mutations and impaired glucose utilization are potential biomarkers for identifying tumours with increased sensitivity to OXPHOS inhibitors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These findings confirm previous studies that analyzed inhibition of either glycolysis or OXPHOS, and observed an increase in the activity of the other pathway (Hao et al., 2010; Jose et al., 2011; Birsoy et al., 2014; Dykens et al., 2008).”
From Combination of Hypoglycemia and Metformin Impairs Tumor Metabolic Plasticity and Growth by Modulating the PP2A-GSK3β-MCL-1 Axis (2019) · cites this paper as Birsoy et al., 2014
In the citing paper
“Cancer cells with reduced OXPHOS due to either mutated mitochondrial DNA or impaired glucose utilization were unable to initiate this adaptive response, and were thus particularly sensitive to glucose deprivation to one-tenth of normal levels (Birsoy et al., 2014).”
From Combination of Hypoglycemia and Metformin Impairs Tumor Metabolic Plasticity and Growth by Modulating the PP2A-GSK3β-MCL-1 Axis (2019) · cites this paper as Birsoy et al., 2014
In the citing paper
“These results are consistent with previous studies reporting the synergism of the metformin/low glucose combination (Birsoy et al., 2014; Zhuang et al., 2014).”
From Combination of Hypoglycemia and Metformin Impairs Tumor Metabolic Plasticity and Growth by Modulating the PP2A-GSK3β-MCL-1 Axis (2019) · cites this paper as Birsoy et al., 2014
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Barretina, J., Caponigro, G., Stransky, N., Venkatesan, K., Margolin, A. A., Kim, S., Wilson, C. J., Lehár, J., Kryukov, G. V., Sonkin, D., et al. (2012) · Nature · doi:10.1038/nature11003 · Cited by 7,950
Regulation of cancer cell metabolism
Cairns, R. A., Harris, I. S., & Mak, T. W. (2011) · Nature Reviews Cancer · doi:10.1038/nrc2981 · Cited by 4,744
Metformin and reduced risk of cancer in diabetic patients
Evans, J. M. M., Donnelly, L. A., Emslie-Smith, A. M., Alessi, D. R., & Morris, A. D. (2005) · BMJ · doi:10.1136/bmj.38415.708634.f7 · Cited by 2,388
OWEN, M. R., DORAN, E., & HALESTRAP, A. P. (2000) · Biochemical Journal · doi:10.1042/bj3480607 · Cited by 2,157
Functional genomics reveal that the serine synthesis pathway is essential in breast cancer
Possemato, R., Marks, K. M., Shaul, Y. D., Pacold, M. E., Kim, D., Birsoy, K., Sethumadhavan, S., Woo, H.-K., Jang, H. G., Jha, A. K., et al. (2011) · Nature · doi:10.1038/nature10350 · Cited by 1,683
Self-citationMetabolite profiling identifies a key role for glycine in rapid cancer cell proliferation
Jain, M., Nilsson, R., Sharma, S., Madhusudhan, N., Kitami, T., Souza, A. L., Kafri, R., Kirschner, M. W., Clish, C. B., & Mootha, V. K. (2012) · Science · doi:10.1126/science.1218595 · Cited by 1,403
Self-citationEl-Mir, M.-Y., Nogueira, V., Fontaine, E., Avéret, N., Rigoulet, M., & Leverve, X. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.1.223 · Cited by 1,399
Hirayama, A., Kami, K., Sugimoto, M., Sugawara, M., Toki, N., Onozuka, H., Kinoshitá, T., Saito, N., Ochiai, A., Tomita, M., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4806 · Cited by 965
Metformin and Cancer Risk in Diabetic Patients: A Systematic Review and Meta-analysis
DeCensi, A., Puntoni, M., Goodwin, P., Cazzaniga, M., Gennari, A., Bonanni, B., & Gandini, S. (2010) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-10-0157 · Cited by 918
Observations on the carbohydrate metabolism of tumours
Crabtree, H. G. (1929) · Biochemical Journal · doi:10.1042/bj0230536 · Cited by 864
Flagged first, then by citations
Cited by
Sorted by citations
Items 301–400 of 710
Li, S.-M. H., Liu, S., Chang, Y., Ho, C., & Huang, S. (2018) · Journal of Biomedical Science · doi:10.1186/s12929-018-0478-5 · Cited by 40
Non-coding RNAs rewire cancer metabolism networks
Lin, X., Wu, Z., Hu, H., Luo, M., & Song, E. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.12.019 · Cited by 37
Ren, Y., Chen, J., Chen, P., Hao, Q., Cheong, L.-K., Tang, M., Hong, L., Hu, X., Yap, C. T., Bay, B., et al. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.02.018 · Cited by 41
Chen, L., Liu, K., Zhao, X., Shen, H., Zhao, K., & Zhu, W. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.759897 · Cited by 39
Glucose Limitation Alters Glutamine Metabolism in MUC1-Overexpressing Pancreatic Cancer Cells
Gebregiworgis, T., Purohit, V., Shukla, S. K., Tadros, S., Chaika, N. V., Abrego, J., Mulder, S. E., Gunda, V., Singh, P. K., & Powers, R. (2017) · Journal of Proteome Research · doi:10.1021/acs.jproteome.7b00246 · Cited by 39
BAI1-Associated Protein 2-Like 1 (BAIAP2L1) Is a Potential Biomarker in Ovarian Cancer
Chao, A., Tsai, C.-L., Jung, S.-M., Chuang, W.-C., Kao, C., Hsu, A., Chen, S., Lin, C.-Y., Lee, Y., Lee, Y. S., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0133081 · Cited by 39
Self-citationGLUT5 (SLC2A5) enables fructose-mediated proliferation independent of ketohexokinase
Liang, R. J., Taylor, S. R., Nahiyaan, N., Song, J., Murphy, C. J., Dantas, E., Cheng, S., Hsu, T.-W., Ramsamooj, S., Grover, R., et al. (2021) · Cancer & Metabolism · doi:10.1186/s40170-021-00246-9 · Cited by 36
Glutamine promotes escape from therapy-induced senescence in tumor cells
Pacifico, F., Badolati, N., Mellone, S., Stornaiuolo, M., Leonardi, A., & Crescenzi, E. (2021) · Aging · doi:10.18632/aging.203495 · Cited by 37
Starting the engine of the powerhouse: mitochondrial transcription and beyond
Miranda, M., Bonekamp, N. A., & Kühl, I. (2022) · Biological Chemistry · doi:10.1515/hsz-2021-0416 · Cited by 34
Inhibition of heme biosynthesis triggers cuproptosis in acute myeloid leukemia
Lewis, A. C., Gruber, E., Franich, R. L., Armstrong, J. M., Kelly, M. J., Opazo, C., Low, Y. C., Flippe, L., Wijanarko, K. J., Rowe, C. L., et al. (2025) · Cell · doi:10.1016/j.cell.2025.10.028 · Cited by 39
Fuentes-Retamal, S., Sandoval-Acuña, C., Peredo-Silva, L., Guzmán‐Rivera, D., Pavani, M., Torrealba, N., Truksa, J., Castro-Castillo, V., Catalán, M., Kemmerling, U., et al. (2020) · Cells · doi:10.3390/cells9020407 · Cited by 38
Disrupting metformin adaptation of liver cancer cells by targeting the TOMM34/ATP5B axis
Jin, P., Jiang, J., Zhou, L., Huang, Z., Qin, S., Chen, H., Peng, L., Zhang, Z., Li, B., Luo, M., et al. (2022) · EMBO Molecular Medicine · doi:10.15252/emmm.202216082 · Cited by 36
Isono, T., Chano, T., Yonese, J., & Yuasa, T. (2016) · Scientific Reports · doi:10.1038/srep25669 · Cited by 35
Metformin reduces HGF-induced resistance to alectinib via the inhibition of Gab1
Chen, H., Lin, C., Peng, T., Hu, C., Lu, C., Li, L., Wang, Y., Han, R., Feng, M., Sun, F., et al. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2307-5 · Cited by 34
Lu, L., Liu, G., Lin, C., Li, K., He, T., Zhang, J., Luo, Z. Y., & Cai, K. (2021) · Advanced Healthcare Materials · doi:10.1002/adhm.202100978 · Cited by 34
Screening in serum-derived medium reveals differential response to compounds targeting metabolism
Abbott, K. L., Ali, A., Casalena, D. E., Do, B. T., Ferreira, R., Cheah, J. H., Soule, C. K., Deik, A., Kunchok, T., Schmidt, D. R., et al. (2023) · Cell chemical biology · doi:10.1016/j.chembiol.2023.08.007 · Cited by 35
Self-citationZhang, Z., Rahme, G. J., Chatterjee, P., Havrda, M. C., & Israel, M. A. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.14 · Cited by 33
Song, I.-S., Jeong, Y. J., Jeong, S. H., Kim, J. E., Han, J., Kim, T. H., & Jang, S. (2019) · Cellular Physiology and Biochemistry · doi:10.33594/000000034 · Cited by 34
Mitochondria and CancerPreprint
Kenny, T. C., & Birsoy, K. (2024) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a041534 · Cited by 40
Self-citationMATE2 Expression Is Associated With Cancer Cell Response to Metformin
Chowdhury, S., Yung, E., Pintilie, M., Muaddi, H., Chaib, S., Yeung, M., Fusciello, M., Sykes, J., Pitcher, B., Hagenkort, A., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0165214 · Cited by 33
Alanine supplementation exploits glutamine dependency induced by SMARCA4/2-loss
Zhu, X., Fu, Z., Chen, S. Y., Ong, D., Aceto, G., Ho, R., Steinberger, J., Monast, A., Pilon, V., Li, E., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-38594-3 · Cited by 33
A comprehensive review on signaling attributes of serine and serine metabolism in health and disease
Wu, D., Zhang, K., Khan, F. A., Pandupuspitasari, N. S., Guan, K., Sun, F., & Huang, C. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.129607 · Cited by 35
Yuan, X., Ma, Y., Gao, R., Cui, S., Wang, Y., Fa, B., Ma, S., Wei, T., Ma, S., & Yu, Z. (2024) · Nature Communications · doi:10.1038/s41467-024-49846-1 · Cited by 31
Mitochondrial Dysfunction Plus High-Sugar Diet Provokes a Metabolic Crisis That Inhibits Growth
Kemppainen, E., Morikka, J., Garipler, G., Tuomela, T., Kiviranta, E., Soga, T., Dunn, C. D., & Jacobs, H. T. (2016) · PLoS ONE · doi:10.1371/journal.pone.0145836 · Cited by 34
Metformin blocks progression of obesity-activated thyroid cancer in a mouse model
Park, J., Kim, W. G., Zhao, L., Enomoto, K., Willingham, M. C., & Cheng, S.-Y. (2016) · Oncotarget · doi:10.18632/oncotarget.8989 · Cited by 34
Xiao, Y., Wang, S., Zong, Q., & Yin, Z. (2018) · AAPS PharmSciTech · doi:10.1208/s12249-018-1070-8 · Cited by 33
Sastre‐Serra, J., Ahmiane, Y., Roca, P., Oliver, J., & Pons, D. G. (2018) · International Journal of Food Sciences and Nutrition · doi:10.1080/09637486.2018.1540558 · Cited by 33
Heterogeneity of Glucose Transport in Lung Cancer
Martinez, C. A., & Scafoglio, C. (2020) · Biomolecules · doi:10.3390/biom10060868 · Cited by 35
Zhen, Y., Liu, K., Shi, L., Shah, S., Xu, Q., Ellis, H., Balasooriya, E. R., Kreuzer, J., Morris, R. T., Baldwin, A. S., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-47514-y · Cited by 36
Targeting cancer energy metabolism: a potential systemic cure for cancer
Kim, S. (2019) · Archives of Pharmacal Research · doi:10.1007/s12272-019-01115-2 · Cited by 33
Window of opportunity clinical trial designs to study cancer metabolism
Aroldi, F., & Lord, S. (2019) · British Journal of Cancer · doi:10.1038/s41416-019-0621-4 · Cited by 32
Repression of LKB1 by miR-17∼92 Sensitizes MYC-Dependent Lymphoma to Biguanide Treatment
Izreig, S., Gariepy, A., Kaymak, I., Bridges, H. R., Donayo, A. O., Bridon, G., DeCamp, L. M., Kitchen-Goosen, S. M., Avizonis, D. Z., Sheldon, R. D., et al. (2020) · Cell Reports Medicine · doi:10.1016/j.xcrm.2020.100014 · Cited by 31
Xu, J., Zhu, K., Wang, Y., & Chen, J. (2022) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-022-04447-7 · Cited by 32
Dermit, M., Casado, P., Rajeeve, V., Wilkes, E. H., Foxler, D. E., Campbell, H., Critchlow, S. E., Sharp, T. V., Gribben, J. G., Unwin, R. J., et al. (2016) · Oncogene · doi:10.1038/onc.2016.435 · Cited by 32
From old to new — Repurposing drugs to target mitochondrial energy metabolism in cancer
Aminzadeh-Gohari, S., Weber, D. D., Vidali, S., Catalano, L., Kofler, B., & Feichtinger, R. G. (2019) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2019.05.025 · Cited by 34
Metformin: From diabetes to cancer to prolongation of life
Sirtori, C. R., Castiglione, S., & Pavanello, C. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107367 · Cited by 38
Wei, Y., Chen, L., Xu, H., Xie, C., Yunfeng, Z., & Zhou, F. (2018) · Radiation Research · doi:10.1667/rr15021.1 · Cited by 31
Bishnu, A., Sakpal, A., Ghosh, N., Choudhury, P., Chaudhury, K., & Ray, P. (2018) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2018.12.016 · Cited by 31
NAD kinase sustains lipogenesis and mitochondrial metabolismthrough fatty acid synthesis
Xu, M., Ding, L., Liang, J., Yang, X. N., Liu, Y. M., Wang, Y., Ding, M., & Huang, X. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.110157 · Cited by 31
Repas, J., Zupin, M., Vodlan, M., Veranič, P., Gole, B., Potočnik, U., & Pavlin, M. (2022) · Cancers · doi:10.3390/cancers14051343 · Cited by 32
Lee, H. Y., Itahana, Y., Schüchner, S., Fukuda, M., Je, H. S., Ogris, E., Virshup, D. M., & Itahana, K. (2018) · Science Signaling · doi:10.1126/scisignal.aam7893 · Cited by 31
Shedd, S. F., Lutz, N. W., & Hull, W. E. (1993) · NMR in Biomedicine · doi:10.1002/nbm.1940060405 · Cited by 31
Valli, A., Morotti, M., Zois, C. E., Albers, P. K., Soga, T., Feldinger, K., Fischer, R., Frejno, M., McIntyre, A., Bridges, E., et al. (2019) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-18-0315 · Cited by 27
Leptin promotes fatty acid oxidation and OXPHOS via the c-Myc/PGC-1 pathway in cancer cells
Liu, Q., Sun, Y., Fei, Z., Yang, Z., Duan, K., Zi, J., Cui, Q., Yu, M., & Xiong, W. (2019) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmz058 · Cited by 30
How Far Are We from Prescribing Fasting as Anticancer Medicine?
Deligiorgi, M. V., Liapi, C. A., & Trafalis, D. T. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21239175 · Cited by 32
Moradi, F., Moffatt, C., & Stuart, J. A. (2021) · Biomolecules · doi:10.3390/biom11081177 · Cited by 30
Effect of Metformin Use on Survival Outcomes in Patients With Metastatic Renal Cell Carcinoma
Hamieh, L., McKay, R. R., Lin, X., Moreira, R. B., Simantov, R., & Choueiri, T. K. (2016) · Clinical Genitourinary Cancer · doi:10.1016/j.clgc.2016.06.017 · Cited by 32
Lorkiewicz, P., Gibb, A., Rood, B. R., He, L., Zheng, Y., Clem, B. F., Zhang, X., & Hill, B. G. (2019) · Scientific Reports · doi:10.1038/s41598-019-50183-3 · Cited by 32
Iversen, A. B. B., Horsman, M. R., Jakobsen, S., Jensen, J., Garm, C., Jessen, N., Breining, P., Frøkiær, J., & Busk, M. (2017) · Scientific Reports · doi:10.1038/s41598-017-10010-z · Cited by 29
Emerging strategies to target cancer metabolism and improve radiation therapy outcomes
Kery, M., & Papandreou, I. (2020) · British Journal of Radiology · doi:10.1259/bjr.20200067 · Cited by 33
Advances in metformin‑based metabolic therapy for non‑small cell lung cancer (Review)
Chen, N., Zhou, Y.-S., Wang, L.-C., & Huang, J. (2022) · Oncology Reports · doi:10.3892/or.2022.8266 · Cited by 29
Application and outlook of electrochemical technology in single-cell analysis
Huang, K., Wang, Y. H., Zhang, H., Wang, T. Y., Liu, X. H., Liu, L., Jiang, H., & Wang, X. M. (2023) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2023.115741 · Cited by 30
Self-citationTargeting respiratory complex I to prevent the Warburg effect
Vatrinet, R., Iommarini, L., Kurelac, I., Luise, M. D., Gasparre, G., & Porcelli, A. M. (2015) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2015.01.017 · Cited by 31
Nam, M., Xia, W., Mir, H., Jerrett, A. E., Spinelli, J. B., Huang, T. T., & Possemato, R. (2024) · Nature Metabolism · doi:10.1038/s42255-024-01166-w · Cited by 32
Self-citationHarnessing Antioxidants in Cancer Therapy: Opportunities, Challenges, and Future Directions
Liu, Y., Wu, G., Feng, L., Li, J., Xia, Y., Guo, W., & Zhao, K. (2025) · Antioxidants · doi:10.3390/antiox14060674 · Cited by 32
Liu, X., Yang, Z., Ge, C., Li, H., Hao, M., Wan, C., Song, Y., Li, B., & Dong, Q. (2020) · CCS Chemistry · doi:10.31635/ccschem.020.202000484 · Cited by 28
Ek, F., Blom, K., Selvin, T., Rudfeldt, J., Andersson, C. R., Senkowski, W., Bréchot, C., Nygren, P., Larsson, R. L., Jarvius, M., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-12519-4 · Cited by 27
Mitochondrial Changes in Cancer
Rao, S. G. (2016) · Handbook of experimental pharmacology · doi:10.1007/164_2016_40 · Cited by 30
Sela, Y., Li, J., Maheswaran, S., Norgard, R. J., Yuan, S., Hubbi, M. E., Doepner, M., Xu, J. P., Ho, E. S., Mesaros, C., et al. (2022) · Cancer Research · doi:10.1158/0008-5472.can-22-0431 · Cited by 27
Maaß, C., Dallas, M. R., LaBarge, M. E., Shockley, M., Valdez, J., Geishecker, E., Stokes, C. L., Griffith, L. G., & Cirit, M. (2018) · Scientific Reports · doi:10.1038/s41598-018-25971-y · Cited by 26
Rebsamen, M., Girardi, E., Sedlyarov, V., Scorzoni, S., Παπακώστας, Κ., Vollert, M., Konecka, J., Gürtl, B., Klavins, K., Wiedmer, T., et al. (2022) · Life Science Alliance · doi:10.26508/lsa.202201404 · Cited by 28
Cellular Adaptation Takes Advantage of Atavistic Regression Programs during Carcinogenesis
Gnocchi, D., Nikolić, D., Paparella, R. R., Sabbà, C., & Mazzocca, A. (2023) · Cancers · doi:10.3390/cancers15153942 · Cited by 27
Teh, J. T., Zhu, W., Newgard, C. B., Casey, P. J., & Wang, M. (2019) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-18-0766 · Cited by 27
Fan, F., Fleishman, J. S., Jin, C., Chen, Z., & Dong, H. (2024) · Drug Discovery Today · doi:10.1016/j.drudis.2024.104069 · Cited by 26
Tau, S. S., Chamberlin, M. D., Yang, H., Marotti, J. D., Muskus, P. C., Roberts, A. M., Carmichael, M. M., Cressey, L. E., Dragnev, C. P. C., Demidenko, E., et al. (2025) · Cancer Research · doi:10.1158/0008-5472.can-24-1204 · Cited by 30
Progress in the application and mechanism of metformin in treating non-small cell lung cancer
Li, C., Yang, X., Xi, Y.-R., & Xie, K. (2017) · Oncology Letters · doi:10.3892/ol.2017.5862 · Cited by 26
Kim, S., Im, J. H., Kim, W., Choi, Y. J., Lee, J. Y., Kim, S. K., Kim, S. J., Kwon, S. W., & Kang, K. W. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/5428364 · Cited by 26
Song, I.-S., Jeong, Y. J., Jung, Y., Park, Y., Shim, S., Kim, S. J., Eom, D., Hong, S., Lee, P. C.-W., Kim, S.-U., et al. (2021) · Redox Biology · doi:10.1016/j.redox.2021.102190 · Cited by 28
Rucinskaite, G., Thompson, S. A., Paterson, S., & de la Rica, R. (2017) · Nanoscale · doi:10.1039/c7nr00298j · Cited by 26
van Gisbergen, M. W., Voets, A. M., Biemans, R., Hoffmann, R. F., Drittij-Reijnders, M.-J., Haenen, G. R. M. M., Heijink, I. H., Rouschop, K. M. A., Dubois, L. J., & Lambin, P. (2017) · PLoS ONE · doi:10.1371/journal.pone.0182508 · Cited by 28
Ma, Z., Chen, H., Xia, Z., You, J., Han, C., Wang, S., Xia, W., Bai, Y., Liu, T., Xu, L., et al. (2023) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-023-02723-z · Cited by 25
Bioenergetic profiling of Trypanosoma cruzi life stages using Seahorse extracellular flux technology
Tomko, S. S., Pereira, C. F., Dumoulin, P. C., Caradonna, K. L., & Burleigh, B. A. (2016) · Molecular and Biochemical Parasitology · doi:10.1016/j.molbiopara.2016.07.001 · Cited by 25
Tumor Cell-Intrinsic Immunometabolism and Precision Nutrition in Cancer Immunotherapy
Cuyàs, E., Verdura, S., Martín-Castillo, B., Alarcón, T., Lupu, R., Bosch‐Barrera, J., & Menéndez, J. A. (2020) · Cancers · doi:10.3390/cancers12071757 · Cited by 26
Schwarzer, A., Holtmann, H., Brugman, M. H., Meyer, J., Schauerte, C., Zuber, J. A., Steinemann, D., Schlegelberger, B., Li, Z., & Baum, C. (2014) · Oncogene · doi:10.1038/onc.2014.290 · Cited by 26
Preventing Alzheimer's disease by means of natural selection
Demetrius, L., & Driver, J. A. (2014) · Journal of The Royal Society Interface · doi:10.1098/rsif.2014.0919 · Cited by 24
Blecha, J., Novais, S. M., Rohlenová, K., Novotná, E., Lettlová, S., Schmitt, S., Zischka, H., Neužil, J., & Rohlena, J. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.07.033 · Cited by 25
Metabolism in the Tumor Microenvironment
Montenegro, F., & Indraccolo, S. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-44518-8_1 · Cited by 26
Yeh, S., Chang, C.-A., Li, C., Wang, L. H.-C., & Chen, B. (2019) · Oncotarget · doi:10.18632/oncotarget.26940 · Cited by 24
An in-silico study of cancer cell survival and spatial distribution within a 3D microenvironment
Cortesi, M., Liverani, C., Mercatali, L., Ibrahim, T., & Giordano, E. (2020) · Scientific Reports · doi:10.1038/s41598-020-69862-7 · Cited by 24
Identification of mitochondrial RNA polymerase as a potential therapeutic target of osteosarcoma
Han, Q., Zhang, X.-Y., Yan, P., Chen, S., Liu, F., Zhu, Y.-R., & Tian, Q. (2021) · Cell Death Discovery · doi:10.1038/s41420-021-00780-x · Cited by 24
Chen, H., Wang, Y., Lin, C., Lu, C., Han, R., Jiao, L., Li, L., & He, Y. (2017) · Oncotarget · doi:10.18632/oncotarget.21225 · Cited by 23
Beyond glucose and Warburg: finding the sweet spot in cancer metabolism models
Hammond, N. G., Cameron, R. B., & Faubert, B. (2024) · npj Metabolic Health and Disease · doi:10.1038/s44324-024-00017-2 · Cited by 23
Dalton, K. M., Lochmann, T. L., Floros, K. V., Calbert, M. L., Kurupi, R., Stein, G. T., McClanaghan, J., Murchie, E., Egan, R. K., Greninger, P., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2009620118 · Cited by 24
Yu, Y., Chen, J., Liu, S., & Cheng, D. (2021) · Journal of Materials Chemistry B · doi:10.1039/d1tb01143j · Cited by 23
Aass, K. R., Mjelle, R., Kastnes, M. H., Tryggestad, S. S., van den Brink, L. M., Roseth, I. A., Westhrin, M., Zahoor, M., Moen, S. H., Nedal, T. M. V., et al. (2021) · iScience · doi:10.1016/j.isci.2021.103605 · Cited by 24
Wild-type IDH1 inhibition enhances chemotherapy response in melanoma
Zarei, M., Hajihassani, O., Hue, J. J., Graor, H. J., Loftus, A. W., Rathore, M. G., Gohar, A. V., Asara, J. M., Winter, J. M., & Rothermel, L. D. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-022-02489-w · Cited by 22
Li, X., Ze, X., Zhou, S., Hu, Z., He, C., Jia, Y., Liu, L., Wang, T., Li, J., Xu, S., et al. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c00058 · Cited by 23
Self-citationCancer in growth hormone excess and growth hormone deficit
Guevara‐Aguirre, J., Peña, G., Acosta, W., Pazmiño, G., Saavedra, J., Soto, L., Lescano, D., Guevara, A., & Gavilanes, A. W. D. (2023) · Endocrine Related Cancer · doi:10.1530/erc-22-0402 · Cited by 24
Shum, M., Houde, V. P., Bellemare, V., Moreira, R. J., Bellmann, K., St‐Pierre, P., Viollet, B., Foretz, M., & Marette, A. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.008488 · Cited by 22
Targeting the metabolism of cancer stem cells by energy disruptor molecules
Dadgar, T., Ebrahimi, N., Gholipour, A. R., Akbari, M., Khani, L., Ahmadi, A., & Hamblin, M. R. (2021) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2021.103545 · Cited by 22
Chao, R., Nishida, M., Yamashita, N., Tokumasu, M., Zhao, W., Kudo, I., & Udono, H. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.864225 · Cited by 23
Padinharayil, H., Rai, V., & George, A. (2023) · Cancers · doi:10.3390/cancers15041070 · Cited by 26
Metformin Use in Relation With Survival Outcomes of Patients With Renal Cell Carcinoma
Cheng, J. J. S., Li, H., Tan, H. S., Tan, P. H., Ng, L. G., Ng, Q. S., Toh, C., Kanesvaran, R., & Tan, M. (2015) · Clinical Genitourinary Cancer · doi:10.1016/j.clgc.2015.12.012 · Cited by 22
Kalyanaraman, B., Cheng, G., Hardy, M., Ouari, O., Sikora, A., Zielonka, J., & Dwinell, M. B. (2017) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-017-0796-3 · Cited by 22
Wang, T., Wang, L., Wang, G., & Zhuang, Y. (2020) · Bioresources and Bioprocessing · doi:10.1186/s40643-020-00325-7 · Cited by 21
Self-citationNovel Mitochondria-targeted Drugs for Cancer Therapy
Fialová, J. L., Raudenská, M., Jakubek, M., Kejík, Z., Pavel Martasek, E., Babula, P., Matkowski, A., Filipenský, P., & Masařík, M. (2020) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557520666201118153242 · Cited by 22
Mitochondrial Inhibition: a Treatment Strategy in Cancer?
Bueno, M. J., Ruiz-Sepulveda, J. L., & Quintela-Fandiño, M. (2021) · Current Oncology Reports · doi:10.1007/s11912-021-01033-x · Cited by 22
Song, I.-S., Jeong, Y. J., Seo, Y. J., Byun, J. M., Kim, Y. N., Jeong, D. H., Han, J., Kim, K. T., & Jang, S. (2017) · Oncotarget · doi:10.18632/oncotarget.21580 · Cited by 22
Wang, X., Li, H., Li, J., Lei, L., Xu, J., Sun, H., Li, J., Jiang, J., Li, H., Tang, M., et al. (2025) · Science China Life Sciences · doi:10.1007/s11427-024-2834-8 · Cited by 23
Zhang, R., Ji, J., Blaženović, I., Pi, F., Wang, T., Zhang, Y., & Sun, X. (2018) · Toxins · doi:10.3390/toxins10110441 · Cited by 23
Self-citation
Metadata
- Authors
- Birsoy, K., Possemato, R., Lorbeer, F. K., Bayraktar, E. C., Thiru, P., Yucel, B., Wang, T., Chen, W. W., Clish, C. B., & Sabatini, D. M.
- Affiliations
- Broad Institute (US)
- Whitehead Institute for Biomedical Research (US)
- Corresponding author
- Sabatini, David M.
- ORCID
- Venue
- Nature
- Published
- 2014-03-16
- Volume
- 508
- Issue
- 7494
- Pages
- 108-112
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4012432
- OpenAlex
- W2104696999
- Cited by
- 710
- References
- 27
- Citations by year
- 2026: 17 · 2025: 44 · 2024: 58 · 2023: 46 · 2022: 60 · 2021: 75 · 2020: 83 · 2019: 71 · 2018: 51 · 2017: 49 · 2016: 61 · 2015: 59 · 2014: 35
- FWCI
- 21.80
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Howard Hughes Medical Institute
- National Cancer Institute (CA129105, K99CA168940, CA103866, R01CA103866, R01CA129105, R00CA168940)
- National Institute of General Medical Sciences (T32GM007287)
- National Institute of Allergy and Infectious Diseases (AI-07389, T32AI007389)
- National Institute of Diabetes and Digestive and Kidney Diseases (P30DK043351)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Keywords
- glucose limitation, biguanides, mitochondrial oxidative phosphorylation, cancer metabolism, mitochondrial DNA mutations, complex I, antidiabetic drugs, OXPHOS inhibitors, continuous flow culture, tumor microenvironment, NDI1, glucose utilization, cancer cell lines, drug sensitivity biomarkers
- MeSH terms
- Adenosine Triphosphate, Animals, Biguanides, Culture Media, DNA, Mitochondrial, Glucose, Humans, Hypoglycemic Agents, Male, Mitochondria, Mutation, Neoplasm Transplantation, Neoplasms, Oxidative Phosphorylation, Phenformin, Cell Culture Techniques, Xenograft Model Antitumor Assays, Saccharomyces cerevisiae Proteins, RNA Interference, Electron Transport Complex I, Cell Line, Tumor, Cell Proliferation, Mice, Molecular Typing
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
